Market revenue in 2023 | USD 6.2 million |
Market revenue in 2030 | USD 13.0 million |
Growth rate | 11.1% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 61.29% in 2023. Horizon Databook has segmented the Malaysia pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The government and private sector investments in R&D are expected to stimulate the demand in the pharmaceutical sterility testing services market. The increasing funding for scientific research and drug development projects is expected to improve the demand for sterility services.
Malaysia has been making efforts to strengthen its pharmaceutical industry, which is expected to improve the demand for sterility testing services. These services are essential for ensuring the safety, efficacy, and quality of pharmaceutical products.
Moreover, the government is encouraging private investments and public-private collaborations in the pharma sector, contributing to market growth. For instance, in August 2023, the first central oncology laboratory dedicated to clinical trials was inaugurated in Malaysia.
Horizon Databook provides a detailed overview of country-level data and insights on the Malaysia pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into Malaysia pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account